logo

BridgeBio Pharma Inc (BBIO) Stock: The Story of a 52-Week Stock Range

CSCO Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. BridgeBio Pharma Inc’s current trading price is -44.64% away from its 52-week high, while its distance from the 52-week low is 13.48%. The stock’s price range for this period has been between $21.62 and $44.32 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.88 million for the day, a number notably lower than the average daily volume of 1.85 million over the last three months.

BridgeBio Pharma Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $44.32 on 12/28/23, while the lowest value for the same period was recorded at $21.62 on 06/24/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

BridgeBio Pharma Inc (BBIO) has experienced a quarterly decline of -4.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.61B and boasts a workforce of 550 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 26.68, with a change in price of -4.69. Similarly, BridgeBio Pharma Inc recorded 2,030,019 in trading volume during the last 100 days, posting a change of -16.12%.

BBIO Stock Stochastic Average

BridgeBio Pharma Inc’s raw stochastic average for the past 50 days is presently 11.66%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 6.72%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 11.02% and 13.67%, respectively.

BBIO Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -39.23%.However, over the last six months, we can see a stronger performance of -12.84%. Over the last 30 days, the price of BBIO has leaped by -20.00%. And in the last five days, it has surged by 0.22%.

Most Popular